List of works - Lisa Palermo

Association of BMD and FRAX score with risk of fracture in older adults with type 2 diabetes

scientific article published on June 2011

Bisphosphonates and fractures of the subtrochanteric or diaphyseal femur.

scientific article

Bone mineral density and prevalent vertebral fractures in men and women

scientific article published on 20 November 2003

Circulating sclerostin associated with vertebral bone marrow fat in older men but not women

scientific article

Does a history of non-vertebral fracture identify women without osteoporosis for treatment?

scientific article published on 6 May 2008

Effect of Once-Yearly Zoledronic Acid Five Milligrams on Fracture Risk and Change in Femoral Neck Bone Mineral Density

Effect of once-yearly zoledronic acid five milligrams on fracture risk and change in femoral neck bone mineral density

scientific article published on 30 June 2009

Effects of Continuing or Stopping Alendronate After 5 Years of Treatment. The Fracture Intervention Trial Long-term Extension (FLEX): A Randomized Trial

article

Effects of continuing or stopping alendronate after 5 years of treatment: the Fracture Intervention Trial Long-term Extension (FLEX): a randomized trial

scientific article published on December 2006

Efficacy of continued alendronate for fractures in women with and without prevalent vertebral fracture: the FLEX trial

scientific article published in May 2010

Elevations in serum and urinary calcium with parathyroid hormone (1-84) with and without alendronate for osteoporosis

scientific article published on 12 December 2006

Fracture prediction after discontinuation of 4 to 5 years of alendronate therapy: the FLEX study

scientific article published on July 2014

Fracture risk in diabetic elderly men: the MrOS study

scientific article

Long-term risk of incident vertebral fractures

scientific article

Lumbar spine listhesis in older African American women

scientific article published in July 2003

Once-yearly zoledronic acid and days of disability, bed rest, and back pain: Randomized, controlled HORIZON Pivotal Fracture Trial ⬇️

scientific article published on May 1, 2011

One year of alendronate after one year of parathyroid hormone (1-84) for osteoporosis

scientific article published in August 2005

Prediction of incident hip fracture with the estimated femoral strength by finite element analysis of DXA Scans in the study of osteoporotic fractures.

scientific article

Prediction of new clinical vertebral fractures in elderly men using finite element analysis of CT scans ⬇️

scientific article published on April 1, 2012

Prevalent vertebral fractures in black women and white women

scientific article published on September 2008

Reassessment of fracture risk in women after 3 years of treatment with zoledronic acid: when is it reasonable to discontinue treatment?

scientific article published in December 2014

Relationship between pretreatment rate of bone loss and bone density response to once-yearly ZOL: HORIZON-PFT extension study

scientific article published on 01 March 2015

Risk Factors for a First-Incident Radiographic Vertebral Fracture in Women 65 Years of Age: The Study of Osteoporotic Fractures

article by Michael C Nevitt et al published January 2005 in Journal of Bone and Mineral Research

Risk factors for a first-incident radiographic vertebral fracture in women > or = 65 years of age: the study of osteoporotic fractures

scientific article published on 11 October 2004

Risk factors for subtrochanteric and diaphyseal fractures: the study of osteoporotic fractures

scientific article published on 23 January 2013

Six months of parathyroid Hormone (1-84) administered concurrently versus sequentially with monthly ibandronate over two years: the PTH and ibandronate combination study (PICS) randomized trial

scientific article published on 12 July 2012

The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis

scientific article published on 20 September 2003

Thiazolidinedione use and bone loss in older diabetic adults

scientific article

Use of Alendronate After 5 Years of Treatment—Reply

scientific article published in The Journal of the American Medical Association

Vertebral bone marrow fat associated with lower trabecular BMD and prevalent vertebral fracture in older adults

scientific article published on 3 April 2013

List of works by Lisa Palermo

Association of BMD and FRAX score with risk of fracture in older adults with type 2 diabetes

Bisphosphonates and fractures of the subtrochanteric or diaphyseal femur.

Bone mineral density and prevalent vertebral fractures in men and women

Circulating sclerostin associated with vertebral bone marrow fat in older men but not women

Does a history of non-vertebral fracture identify women without osteoporosis for treatment?

Effect of Once-Yearly Zoledronic Acid Five Milligrams on Fracture Risk and Change in Femoral Neck Bone Mineral Density

Effect of once-yearly zoledronic acid five milligrams on fracture risk and change in femoral neck bone mineral density

Effects of Continuing or Stopping Alendronate After 5 Years of Treatment. The Fracture Intervention Trial Long-term Extension (FLEX): A Randomized Trial

Effects of continuing or stopping alendronate after 5 years of treatment: the Fracture Intervention Trial Long-term Extension (FLEX): a randomized trial

Efficacy of continued alendronate for fractures in women with and without prevalent vertebral fracture: the FLEX trial

Elevations in serum and urinary calcium with parathyroid hormone (1-84) with and without alendronate for osteoporosis

Fracture prediction after discontinuation of 4 to 5 years of alendronate therapy: the FLEX study

Fracture risk in diabetic elderly men: the MrOS study

Long-term risk of incident vertebral fractures

Lumbar spine listhesis in older African American women

Once-yearly zoledronic acid and days of disability, bed rest, and back pain: Randomized, controlled HORIZON Pivotal Fracture Trial ⬇️

One year of alendronate after one year of parathyroid hormone (1-84) for osteoporosis

Prediction of incident hip fracture with the estimated femoral strength by finite element analysis of DXA Scans in the study of osteoporotic fractures.

Prediction of new clinical vertebral fractures in elderly men using finite element analysis of CT scans ⬇️

Prevalent vertebral fractures in black women and white women

Reassessment of fracture risk in women after 3 years of treatment with zoledronic acid: when is it reasonable to discontinue treatment?

Relationship between pretreatment rate of bone loss and bone density response to once-yearly ZOL: HORIZON-PFT extension study

Risk Factors for a First-Incident Radiographic Vertebral Fracture in Women 65 Years of Age: The Study of Osteoporotic Fractures

Risk factors for a first-incident radiographic vertebral fracture in women > or = 65 years of age: the study of osteoporotic fractures

Risk factors for subtrochanteric and diaphyseal fractures: the study of osteoporotic fractures

Six months of parathyroid Hormone (1-84) administered concurrently versus sequentially with monthly ibandronate over two years: the PTH and ibandronate combination study (PICS) randomized trial

The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis

Thiazolidinedione use and bone loss in older diabetic adults

Use of Alendronate After 5 Years of Treatment—Reply

Vertebral bone marrow fat associated with lower trabecular BMD and prevalent vertebral fracture in older adults

What Proportion of Incident Radiographic Vertebral Deformities Is Clinically Diagnosed and Vice Versa?